Newron Pharmaceuticals S.p.A. (SWX:NWRN)
7.92
-0.26 (-3.18%)
Oct 2, 2026, 1:18 PM CET
Newron Pharmaceuticals Employees
Newron Pharmaceuticals had 27 employees as of December 31, 2025. The number of employees increased by 5 or 22.73% compared to the previous year.
Employees
27
Change (1Y)
5
Growth (1Y)
22.73%
Revenue / Employee
356.15K CHF
Profits / Employee
-1.01M CHF
Market Cap
173.73M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 27 | 5 | 22.73% |
| Dec 31, 2024 | 22 | 0 | - |
| Dec 31, 2023 | 22 | -1 | -4.35% |
| Dec 31, 2022 | 23 | -2 | -8.00% |
| Dec 31, 2021 | 25 | 2 | 8.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bachem Holding AG | 2,725 |
| Idorsia | 487 |
| Basilea Pharmaceutica AG | 200 |
| Molecular Partners AG | 134 |
| Santhera Pharmaceuticals Holding AG | 94 |
| BioVersys AG | 38 |
| Xlife Sciences AG | 20 |
| Addex Therapeutics | 3 |
Newron Pharmaceuticals News
- 4 days ago - FDA Maintains U.S. Enrollment Hold On Newron's Phase 3 ENIGMA-TRS 2 Schizophrenia Study - Nasdaq
- 10 days ago - Newron Pharmaceuticals Earnings release: H1 2026 - Filings
- 10 days ago - Newron Pharmaceuticals Quarterly report: H1 2026 - Filings
- 15 days ago - Newron Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 3 months ago - Newron Provides Update Following Type A Meeting With the FDA - Business Wire
- 4 months ago - Newron Pharmaceuticals to Participate in June Investor Conferences - Business Wire
- 5 months ago - Newron Pharma price target lowered to CHF 44 from CHF 48 at H.C. Wainwright - TheFly
- 6 months ago - Newron Pharma price target raised to CHF 48 from CHF 43 at H.C. Wainwright - TheFly